These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32563238)

  • 1. Nanotherapeutics for Neurological Disorders.
    Baboota S; Ali J
    Curr Pharm Des; 2020; 26(19):2193-2194. PubMed ID: 32563238
    [No Abstract]   [Full Text] [Related]  

  • 2. Nanotherapeutics and the Brain.
    Joseph A; Nance E
    Annu Rev Chem Biomol Eng; 2022 Jun; 13():325-346. PubMed ID: 35320699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nose-to-brain drug delivery by nanoparticles in the treatment of neurological disorders.
    Ong WY; Shalini SM; Costantino L
    Curr Med Chem; 2014; 21(37):4247-56. PubMed ID: 25039773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology enabled regenerative medicine for neurological disorders.
    Lowe TL; Agrahari V; Kannan RM; Kannan S
    Adv Drug Deliv Rev; 2019 Aug; 148():1-2. PubMed ID: 31787167
    [No Abstract]   [Full Text] [Related]  

  • 5. Current Perspectives on Delivery Systems Using Extracellular Vesicles in Neurological Disease.
    Tran PHL; Duan W; Lee BJ; Tran TTD
    Curr Pharm Des; 2020; 26(7):764-771. PubMed ID: 31894742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Use of Nanotechnology in the Treatment of Neurological Disorders.
    Chhabra R; Tosi G; Grabrucker AM
    Curr Pharm Des; 2015; 21(22):3111-30. PubMed ID: 26027574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology-based Drug Delivery as Therapeutic Modalities for Neurological Diseases.
    Ali J; Baboota S
    Curr Neuropharmacol; 2023; 21(3):491-492. PubMed ID: 36960642
    [No Abstract]   [Full Text] [Related]  

  • 8. [Targeted nanomedicine in diagnostics and therapy of neurological diseases].
    Bertalan F; László B; Attila V
    Ideggyogy Sz; 2013 May; 66(5-6):155-63. PubMed ID: 23909015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglia--a therapeutic target in neurological diseases and disorders.
    Kaur C; Ling EA
    CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):719. PubMed ID: 24047518
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipid-based nanoformulations in the treatment of neurological disorders.
    Pottoo FH; Sharma S; Javed MN; Barkat MA; Harshita ; Alam MS; Naim MJ; Alam O; Ansari MA; Barreto GE; Ashraf GM
    Drug Metab Rev; 2020 Feb; 52(1):185-204. PubMed ID: 32116044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New frontiers in G protein-coupled receptor regulation of neurological disorders.
    Maudsley S
    CNS Neurol Disord Drug Targets; 2010 Nov; 9(5):525. PubMed ID: 20632974
    [No Abstract]   [Full Text] [Related]  

  • 12. Nanotheranostics, a future remedy of neurological disorders.
    Sharma M; Dube T; Chibh S; Kour A; Mishra J; Panda JJ
    Expert Opin Drug Deliv; 2019 Feb; 16(2):113-128. PubMed ID: 30572726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of nanotechnology in developing new therapies for diseases of the nervous system.
    Jain KK
    Nanomedicine (Lond); 2006 Jun; 1(1):9-12. PubMed ID: 17716203
    [No Abstract]   [Full Text] [Related]  

  • 14. New Drug Treatment Paradigms for Metabolic and Neurological Disorders.
    Sivanesan S
    Curr Pharm Des; 2019; 25(33):3499. PubMed ID: 31774043
    [No Abstract]   [Full Text] [Related]  

  • 15. Nanomaterial applications for neurological diseases and central nervous system injury.
    Huang L; Hu J; Huang S; Wang B; Siaw-Debrah F; Nyanzu M; Zhang Y; Zhuge Q
    Prog Neurobiol; 2017 Oct; 157():29-48. PubMed ID: 28743465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug targeting strategies into the brain for treating neurological diseases.
    Barnabas W
    J Neurosci Methods; 2019 Jan; 311():133-146. PubMed ID: 30336221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal magnetic drug targeting for localized delivery of therapeutics in the CNS.
    Venugopal I; Habib N; Linninger A
    Nanomedicine (Lond); 2017 Apr; 12(8):865-877. PubMed ID: 28339319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial: Current Strategies for Drug Discovery Targeting Neurological Autoimmune Diseases.
    Skundric DS
    Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):3. PubMed ID: 29474167
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemical & biological therapeutic approaches to neurological disorders.
    François I
    Drug News Perspect; 2010 Oct; 23(8):524-31. PubMed ID: 21031169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress of drug nanoformulations targeting to brain.
    Khan AR; Yang X; Fu M; Zhai G
    J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.